Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178

Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178–211

Published:2018-02 Issue:2 Volume:73 Page:e31
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

von Eyben Finn E.,Virgolini Irene,Roviello Giandomenico

Publisher

Elsevier BV

Subject

Urology

Reference5 articles.

1. Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017;Gillessen;Eur Urol,2018

2. Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment: results of an Italian multicentre study;Caffo;Eur Urol,2015

3. Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer;Kongsted;Anticancer Drugs,2016

4. Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis;Calopedos;Prostate Cancer Prostatic Dis.,2017

5. von Eyben FE, Kiljunen T, Kairemo K, Uprimny C, Virgolini I, Joensuu T. Radioligand therapy with 177Lu-PSMA-617 for a patient with lymph node metastatic prostate cancer. Oncotarget. In press.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen Deprivation Therapy in Prostate Cancer: A Practical Approach to Complex Clinical Scenarios;EMJ Urology;2024-05-21

2. Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest;BMC Cancer;2024-04-16

3. Three Cases of Bone Metastases from Lung Cancer with Bone Scintigraphy Showing the Accumulation in the Mandible Before the Appearance of Symptoms of Osteonecrosis of the Jaw;Haigan;2023-04-20

4. Technical Advancements in Abdominal Diffusion-weighted Imaging;Magnetic Resonance in Medical Sciences;2023

5. Long Term Results of Elective Nodal Salvage Radiotherapy in Oligometastatic Prostate Cancer : A Mono-Institutional Series;annals of urologic oncology;2022-09-30